Freedom from Price Gouging Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 20, 2021)
Freedom from Price Gouging Act
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.
What just happenedApr 21, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseApr 20, 2021
- Apr 21, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 20, 2021Committee
Referred to the Subcommittee on Social Security.
Social Security Subcommittee - Apr 20, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 20, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Apr 20, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Apr 20, 2021IntroReferralIntro-H
Introduced in House
- Apr 20, 2021IntroReferral1000
Introduced in House